Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Editas Medicine (EDIT) over the last 10 years, with Q3 2025 value amounting to $183.6 million.

  • Editas Medicine's Total Non-Current Liabilities rose 2351.67% to $183.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $183.6 million, marking a year-over-year increase of 2351.67%. This contributed to the annual value of $204.2 million for FY2024, which is 3776.37% up from last year.
  • Latest data reveals that Editas Medicine reported Total Non-Current Liabilities of $183.6 million as of Q3 2025, which was up 2351.67% from $186.8 million recorded in Q2 2025.
  • In the past 5 years, Editas Medicine's Total Non-Current Liabilities ranged from a high of $204.2 million in Q4 2024 and a low of $142.5 million during Q1 2024
  • For the 4-year period, Editas Medicine's Total Non-Current Liabilities averaged around $168.0 million, with its median value being $153.6 million (2022).
  • Per our database at Business Quant, Editas Medicine's Total Non-Current Liabilities crashed by 350.49% in 2023 and then surged by 3776.37% in 2024.
  • Over the past 4 years, Editas Medicine's Total Non-Current Liabilities (Quarter) stood at $153.6 million in 2022, then fell by 3.5% to $148.3 million in 2023, then skyrocketed by 37.76% to $204.2 million in 2024, then fell by 10.1% to $183.6 million in 2025.
  • Its Total Non-Current Liabilities was $183.6 million in Q3 2025, compared to $186.8 million in Q2 2025 and $194.9 million in Q1 2025.